Infections in Biological and Targeted Synthetic Drug Use in Rheumatoid Arthritis: Where do We Stand? A Scoping Review and Meta-analysis

INTRODUCTION: The advent of biological and targeted synthetic therapies has revolutionized rheumatoid arthritis (RA) treatment. However, this has come at the price of an increased risk of infections. The aim of this study was to present an integrated overview of both serious and non-serious infectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergmans, Barbara J. M., Gebeyehu, Biniyam Y., van Puijenbroek, Eugène P., Van Deun, Katrijn, Kleinberg, Bennett, Murk, Jean-Luc, de Vries, Esther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469142/
https://www.ncbi.nlm.nih.gov/pubmed/37365454
http://dx.doi.org/10.1007/s40744-023-00571-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469142/
https://www.ncbi.nlm.nih.gov/pubmed/37365454
http://dx.doi.org/10.1007/s40744-023-00571-z

Ejemplares similares